Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now displayed on the page, signaling a minor platform update. This change does not modify study content or how the page appears to users.
    Difference
    0.0%
    Check dated 2026-06-29T06:22:59.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed and introduces new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), plus a revision notice.
    Difference
    0.3%
    Check dated 2026-06-14T20:21:47.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.4 to v3.5.5, indicating a small maintenance update to the study record page.
    Difference
    0.0%
    Check dated 2026-06-07T15:38:58.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed, indicating a version update for the study record.
    Difference
    0.0%
    Check dated 2026-05-17T05:29:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s footer software revision was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:34.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:23:22.000Z thumbnail image

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.